Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography

Intervirology

Volumn 51, Issue SUPPL. 1, 2008, Pages 27-33

  Tatsumi, Chie ^a   Kudo, Masatoshi ^a   Ueshima, Kazuomi ^a   Kitai, Satoshi ^a   Takahashi, Shunsuke ^a   Inoue, Tatsuo ^a   Minami, Yasunori ^a   Chung, Hobyung ^a   Maekawa, Kiyoshi ^a   Fujimoto, Kenji ^b   Akiko, Tonomura ^c   Takeshi, Mitake ^c  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organizaton Minami Wakayama Medical Center   (Japan)

^c HITACHI LTD   (Japan)

Author keywords

Biopsy; Collagen; Elastography; FibroScan; Hyaluronic acid; Real time tissue elastography; Serum fibrotic markers; Type III procollagen N peptide; Type IV collagen 7S domain

Indexed keywords

ASPARTATE AMINOTRANSFERASE; COLLAGEN TYPE 4; HYALURONIC ACID; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ADULT; AGED; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; ELASTOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME TISSUE ELASTOGRAPHY; SERODIAGNOSIS;

BIOLOGICAL MARKERS; CHRONIC DISEASE; COLLAGEN TYPE IV; ELASTICITY IMAGING TECHNIQUES; HUMANS; HYALURONIC ACID; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROTEIN STRUCTURE, TERTIARY; SENSITIVITY AND SPECIFICITY;

EID: 44949152472     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000122602     Document Type: Conference Paper

References (30)

1. Bataller R, Brenner DA: Liver fibrosis. J Clin Invest 2005;115:209-218.
2. Pinzani M, Rombouts K, Colagrande S: Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol 2005;42:S22-S26.
3. Dienstag JL: The role of liver biopsy in chronic hepatitis C. Hepatology 2002;36:S152-S160.
4. Poynard T, Ratziu V, Bedossa P: Appropriateness of liver biopsy. Can J Gastroenterol 2000;14:543-548.
5. Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K: The role of liver biopsy in chronic hepatitis C. Hepatology 2001;33:196-200.
6. Bravo AA, Sheth SG, Chopra S: Liver biopsy. N Engl J Med 2001;344:495-500.
7. Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG, El-Kamary SS, Sulkowski M, Bass EB: Role of liver biopsy in management of chronic hepatitis C: a systemic review. Hepatology 2002;36:161-172.
8. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ: Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986;1:523-525.
9. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614-2618.
10. Bedossa P, Dargère D, Paradis V: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-1457.
11. Colloredo G, Guido M, Sonzogni A, Leandro G: Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003;39:239-244.
12. Gómez-Domínguez E, Mendoza J, Rubio S, Moreno-Monteagudo JA, García-Buey L, Moreno-Otero R: Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther 2006;24:513-518.
13. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F, Beaugrand M, Palau R: Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-1713.
14. Kawamoto M, Mizuguchi T, Katsuramaki T, Nagayama M, Oshima H, Kawasaki H, Nobuoka T, Kimura Y, Hirata K: Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers. World J Gastroenterol 2006;12:4325-4330.
15. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, Colombo M: Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007;56:968-973.
16. Sandrin L, Tanter M, Gennisson JL, Catheline S, Fink M: Shear elasticity probe for soft tissues with 1-D transient elastography. IEEE Trans Ultrason Ferroelectr Freq Control 2002;49:436-446.
17. Verveer C, de Knegt RJ: Non-invasive measurement of liver fibrosis: application of the FibroScan in hepatology. Scand J Gastroenterol 2006;41:85-88.
18. Fujiwara S, Hongou Y, Miyaji K, Asai A, Tanabe T, Fukui H, Tsuda Y, Fukuda A, Masuda D, Arisaka Y, Takii M, Hayashi M, Katsu K: Relationship between liver fibrosis noninvasively measured by FibroScan and blood test. Bull Osaka Med Coll 2007;53:93-105.
19. Foucher J, Chanteloup E, Vergniol J, Castéra L, Le Bail B, Adhoute X, Bertet J, Couzigou P, de Lédinghen V: Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;55:403-408.
20. Lichtinghagen R, Bahr MJ: Noninvasive diagnosis of fibrosis in chronic liver disease. Expert Rev Mol Diagn 2004;4:715-726.
21. Iacobellis A, Fusilli S, Mangia A, Clemente R, Festa V, Giacobbe A, Facciorusso D, Niro G, Conoscitore P, Andriulli A: Ultrasonographic and biochemical parameters in the non-invasive evaluation of liver fibrosis in hepatitis C virus chronic hepatitis. Aliment Pharmacol Ther 2005;22:769-774.
22. Desmet VJ, Gerber M, Hoofnagle JH, et al: Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-1520.
23. Williams AL, Hoofnagle JH: Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis: relationship to cirrhosis. Gastroenterology 1988;95:734-739.
24. Sheth SG, Flamm SL, Gordon FD, Chopra S: AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1988;93:44-48.
25. Reedy DW, Loo AT, Levine RA: AST/ALT ratio ≥ 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C. Dig Dis Sci 1998;43:2156-2159.
26. Park GJ, Lin BP, Ngu MC, Jones DB, Katelaris PH: Aspartate aminotransferase:alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? J Gastroenterol Hepatol 2000;15:386-390.
27. Imperiale TF, Said AT, Cummings OW, Born LJ: Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C. Am J Gastroenterol 2000;95:2328-2332.
28. Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romagnoli P, Testa E, Ceppa P, Testa R: Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 2003;163:218-224.
29. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS: A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526.
30. Fujimoto K, Wada S, Oshita M, Kato M, Tonomura A, Mitake T: Non-invasive evaluation of hepatic fibrosis in patients with chronic hepatitis C using elastography. MEDIX 2007;10(suppl):24-27.